Future of haemophilia outcome assessment: registries are key to optimized treatment
- 19 May 2016
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 279 (6), 498-501
- https://doi.org/10.1111/joim.12504
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Safety surveillance in haemophilia and allied disordersJournal of Internal Medicine, 2016
- Registry‐based outcome assessment in haemophilia: a scoping study to explore the available evidenceJournal of Internal Medicine, 2016
- Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970sBlood, 2013
- Incidence, mortality rates and causes of deaths in haemophilia patients in SwedenHaemophilia, 2013
- Modern haemophilia careThe Lancet, 2012
- Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studiesHaemophilia, 2012
- Non‐thrombotic‐, non‐inhibitor‐associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrand’s disease: a systematic review of prospective studiesHaemophilia, 2012
- A study of variations in the reported haemophilia A prevalence around the worldHaemophilia, 2009
- Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe HemophiliaThe New England Journal of Medicine, 2007
- Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and BJournal of Internal Medicine, 1992